Head-to-head · WeighScore
Andrew Meds vs Hims & Hers
The verdict
Hims & Hers takes it — 75.6/100 to 67.1/100.
Hims & Hers grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mass-market app-first program with nationwide reach and consumer-grade polish.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Andrew Meds | Hims & Hers |
|---|---|---|
| WeighScore | 67.1/100 | 75.6/100 |
| Grade | C | C |
| Site position | #188 | #56 |
| Semaglutide | $199/mo (product page; two live intake funnels price semaglutide differently) | $199/mo |
| Tirzepatide | $299/mo (product page; neither GLP-1 funnel offered tirzepatide when walked) | Not disclosed |
| Coverage | All 50 states plus Washington, D.C. | All 50 states |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #188 · C
Strengths
- States its compounding class in plain language on the product pages — a 503(A) pharmacy or a 503(B) outsourcing facility — which most of the field leaves unstated
- Names the prescribing practice in the footer of every page
- Prices sit on the product pages before any intake, and free expedited shipping is stated rather than added at checkout
- Serves all 50 states and the District of Columbia, stated in the footer without a hedge
Where it loses points
- Three live semaglutide figures the site never reconciles: $199 a month on the product page, $99 a month in the microdosing funnel, and $149 for a four-week supply in the second funnel
- Every Get Started button on the compounded semaglutide page lands on a microdosing intake, which is a different program from the one the page describes
- Both GLP-1 intakes ended offering only semaglutide, so whether tirzepatide can be bought through the current funnels is unclear
- The funnel promises a 100% success guarantee and a money-back weight-loss guarantee while the Terms say refunds are not offered for partially used subscription periods
- The pharmacy class is stated but no pharmacy is named, and no individual clinician or NPI appears anywhere
- An oral tirzepatide product is advertised on both GLP-1 pages and every link to it resolves to a page that does not list it
Site position #56 · C
FDAWarning letter issued to Hims & Hers Health, Inc. dba Hims in September 2025. See the FDA warning-letter database.
Strengths
- Nationwide
- Polished app
- Strong brand trust
Where it loses points
- Tirzepatide pricing inconsistently disclosed
- Industry-wide compounding scrutiny
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.